Tcelna, a potential T-cell therapy for secondary-progressive MS as well as relapsing-remitting MS, is gearing up for its Phase IIb clinical trials. According to Opexa Therapeutics, Tcelna is the first-ever personalized T-cell therapy for MS, which means that the treatment will be … [Read more...]
MIS416 Gets Closer to Trials
On Sept. 3, 2012 Innate Immunotherapeutics announced that it has begun raising $10 million in order to test MIS416, a potential therapy for primary and secondary progressive MS, in Phase IIb clinical trials. MIS416 is thought to work by re-regulating a person’s immune … [Read more...]
Video Gaming and Restoring Physical Activity
If you’ve ever wished your doctor would prescribe you a bunch of video games instead of an exercise program, the Veterans Administration’s Spinal Cord Injury Center in Palo Alto, Calif., may be coming to your entertainment and recovery rescue. Their researchers are working … [Read more...]
